SAN FRANCISCO: A pill taken twice a day has stalled deterioration of the brain in Alzheimer’s patients for the first time.
Scientists announced that the mental decline of participants in a final-stage trial had been halted for 18 months, raising hopes that an effective treatment for the drug, called LMTX, is close at hand.